Pharmacological management of co-morbid conditions at the end of life: is less more?

Sarah McLean1, Barbara Sheehy-Skeffington2, Norma O’Leary2, Aisling O’Gorman2
1Specialist Palliative Care Service, Dochas Centre, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland
2Specialist Palliative Care Service, Dochas Centre, Our Lady of Lourdes Hospital, Drogheda, Ireland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Coebergh JWW, Janssen-Heijnen MLG, Post PN et al (1999) Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993–1996. J Clin Epidemiology 52(12):1131–1136

Feinstein AR (1985) On classifying cancers while treating patients. Arch Int Med 145:1789–1791

Ryan C, O’Mahony D, Kennedy J et al (2009) Potentially inappropriate prescribing in an Irish elderly population in primary care. B J Clin Pharmacol 68(6):936–947

Walsh EK, Cussen K (2010) “Take ten minutes”: a dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J 103(8):236–238

Amarenco P, Labreuche J, Lavallee P (2004) Statins in stroke prevention and carotid atheroscelerosis: systematic review and up-to-date meta-analysis. Stroke 35:2902–2909

Uretsky BF, Young JB, Shahidi FE et al (1993) Randomised study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED investigation group. J Am Coll Cardiol 22(4):955–962

Stevenson J, Miller C, Abernethy AP et al (2004) Managing comorbidities in patients at the end of life. BMJ 329:909–912

Silveira MJ, Segnini Kazanis A, Shevrin MP et al (2008) Statins in the last six months of life: a recognizable life-limiting condition does not decrease their use. J Pall Med 11(5):685–693

Sheehy-Skeffington B, McLean S, Bramwell M, O’Leary N, O’Gorman A (in press) Caregivers experiences of managing medications of palliative care patients at the end of life—a qualitative study

Garfinkel D, Mangin D (2010) Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 170(18):1648–1654

Heeschen C, Hamm CW, Laufs U et al (2002) Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105:1446–1452

McGowan MP, for the Treating to New Target Study Group (2004) There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 110:2333–2335

Arnold EM (1999) The cessation of cancer treatment as a crisis. Soc Work Health Care 29:21–38

Holmes HM, Cox-Hayley JT, Alexander GC et al (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166:605–609

Currow D, Stevenson J, Abernethy A et al (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55:590–595

Hanlon JT, Schmader KE, Samsa GP et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45:1045–1051

Beers MH, Ouslander JG, Rollingher I et al (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 151:1825–1832